StockData
Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc. (ESTA) stock

ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$69.51−0.31 (-0.44%)

Close on Nov 17, 2026Market cap $2.07BP/E –Yield –

Establishment Labs gross margin

Gross margin is gross profit as a percentage of revenue.

Establishment Labs's gross margin for the twelve months ending Sep 30, 2026 was 70.2%. For fiscal 2025 it was 69.3%, against 66.0% the year before. The highest annual figure on record is 69.3% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202569.3%+3.3
FY2024Dec 31, 202466.0%+1.2
FY2023Dec 31, 202364.8%−1.1
FY2022Dec 31, 202265.9%−1.5
FY2021Dec 31, 202167.4%+5.4
FY2020Dec 31, 202062.0%+0.8
FY2019Dec 31, 201961.3%+2.2
FY2018Dec 31, 201859.0%+8.0
FY2017Dec 31, 201751.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202669.1%−1.0
Q2 FY2026Jun 30, 202670.6%+1.9
Q1 FY2026Mar 31, 202670.7%+3.5
Q4 FY2025Dec 31, 202570.5%+2.0
Q3 FY2025Sep 30, 202570.1%+6.2
Q2 FY2025Jun 30, 202568.8%+3.2
Q1 FY2025Mar 31, 202567.2%+1.6
Q4 FY2024Dec 31, 202468.5%+3.3
Q3 FY2024Sep 30, 202463.9%−3.7
Q2 FY2024Jun 30, 202465.6%+3.3
Q1 FY2024Mar 31, 202465.6%+0.9
Q4 FY2023Dec 31, 202365.2%+0.9
Q3 FY2023Sep 30, 202367.7%−0.4
Q2 FY2023Jun 30, 202362.3%−4.3
Q1 FY2023Mar 31, 202364.7%−0.2
Q4 FY2022Dec 31, 202264.3%−4.3
Q3 FY2022Sep 30, 202268.1%+0.5
Q2 FY2022Jun 30, 202266.7%−0.4
Q1 FY2022Mar 31, 202264.8%−1.4
Q4 FY2021Dec 31, 202168.6%+14.3
Q3 FY2021Sep 30, 202167.6%+1.0
Q2 FY2021Jun 30, 202167.1%−2.0
Q1 FY2021Mar 31, 202166.2%+3.0
Q4 FY2020Dec 31, 202054.3%−13.2
Q3 FY2020Sep 30, 202066.6%+4.3
Q2 FY2020Jun 30, 202069.1%+9.1
Q1 FY2020Mar 31, 202063.2%+9.1
Q4 FY2019Dec 31, 201967.5%+7.3
Q3 FY2019Sep 30, 201962.3%+0.2
Q2 FY2019Jun 30, 201960.0%+0.1
Q1 FY2019Mar 31, 201954.2%+0.7
Q4 FY2018Dec 31, 201860.2%+4.6
Q3 FY2018Sep 30, 201862.1%+12.9
Q2 FY2018Jun 30, 201859.9%+12.1
Q1 FY2018Mar 31, 201853.4%–
Q4 FY2017Dec 31, 201755.6%–
Q3 FY2017Sep 30, 201749.2%–
Q2 FY2017Jun 30, 201747.8%–

More Establishment Labs figures

See a number that looks wrong?